As of 2026-02-07, the Relative Valuation of Pfizer Inc (PFE) is 30.66 USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.22 USD, the upside of Pfizer Inc based on Relative Valuation is 12.6%.
The range of the Relative Valuation is 27.48 - 39.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 28.7x | 24.5x |
| Forward P/E multiples | 20.6x - 21.2x | 20.8x |
| Fair Price | 27.48 - 39.28 | 30.66 |
| Upside | 1.0% - 44.3% | 12.6% |
| Date | P/E |
| 2026-02-06 | 19.92 |
| 2026-02-05 | 19.38 |
| 2026-02-04 | 19.59 |
| 2026-02-03 | 18.85 |
| 2026-02-02 | 19.51 |
| 2026-01-30 | 19.35 |
| 2026-01-29 | 19.10 |
| 2026-01-28 | 18.92 |
| 2026-01-27 | 19.39 |
| 2026-01-26 | 18.94 |
| 2026-01-23 | 18.77 |
| 2026-01-22 | 19.10 |
| 2026-01-21 | 18.94 |
| 2026-01-20 | 18.67 |
| 2026-01-16 | 18.77 |
| 2026-01-15 | 18.94 |
| 2026-01-14 | 18.72 |
| 2026-01-13 | 18.40 |
| 2026-01-12 | 18.49 |
| 2026-01-09 | 18.64 |
| 2026-01-08 | 18.50 |
| 2026-01-07 | 18.50 |
| 2026-01-06 | 18.61 |
| 2026-01-05 | 18.42 |
| 2026-01-02 | 18.42 |
| 2025-12-31 | 18.22 |
| 2025-12-30 | 18.28 |
| 2025-12-29 | 18.29 |
| 2025-12-26 | 18.36 |
| 2025-12-24 | 18.31 |
| 2025-12-23 | 18.20 |
| 2025-12-22 | 18.45 |
| 2025-12-19 | 18.43 |
| 2025-12-18 | 18.32 |
| 2025-12-17 | 18.32 |
| 2025-12-16 | 18.68 |
| 2025-12-15 | 19.34 |
| 2025-12-12 | 18.91 |
| 2025-12-11 | 18.88 |
| 2025-12-10 | 18.86 |
| 2025-12-09 | 18.53 |
| 2025-12-08 | 18.85 |
| 2025-12-05 | 19.05 |
| 2025-12-04 | 18.80 |
| 2025-12-03 | 18.71 |
| 2025-12-02 | 18.40 |
| 2025-12-01 | 18.49 |
| 2025-11-28 | 18.83 |
| 2025-11-26 | 18.81 |
| 2025-11-25 | 18.82 |